Restrict Innovation so it fits through pre-defined channels. Unrestrained innovation threatens our established processes. By structuring innovation through rigorous submittal and vetting procedures, we can limit its impact.

Individuals identified as persistent innovators will be enrolled in an involuntary Valium dosage program until the condition subsides. In the event that this program proves unsuccessful, offshoring of the afflicted individuals is recommended to limit organizational damage.

In short, innovation that occurs outside strictly defined channels and processes, or that which engenders substantial changes to established protocols, is counter-productive and needs to be discouraged at all organizational levels.